/C O R R E C T I O N -- MedCana/
MedCana (OTC: SFWJ), a holding company specializing in agricultural technology and the cannabis industry, is exploring opportunities to enter the Australian pharmaceutical cannabis market. The Australian legal cannabis market is projected to reach USD 540.6 million by 2030, with a CAGR of 27.8% from 2024 to 2030.
MedCana aims to establish a presence as both an exporter and licensed producer in Australia. The company's CEO, Gabriel Diaz, highlighted the growing demand for high-quality pharmaceutical cannabis as a perfect opportunity for rapid expansion. MedCana is committed to meeting Australia's rigorous pharmaceutical standards by ensuring all its subsidiaries follow Good Agricultural and Collection Practices (GACP) certification processes.
The expansion into Australia aligns with the country's increasing patient demand, favorable regulatory changes, and expanding access to medicinal cannabis treatments.
MedCana (OTC: SFWJ), una holding specializzata in tecnologia agricola e nel settore della cannabis, sta esplorando opportunità per entrare nel mercato australiano della cannabis farmacologica. Si prevede che il mercato legale della cannabis in Australia raggiunga 540,6 milioni di USD entro il 2030, con un tasso di crescita annuale composto (CAGR) del 27,8% dal 2024 al 2030.
MedCana mira a stabilire una presenza sia come esportatore che come produttore autorizzato in Australia. Il CEO dell'azienda, Gabriel Diaz, ha evidenziato la crescente domanda di cannabis farmacologica di alta qualità come un'opportunità perfetta per un'espansione rapida. MedCana si impegna a soddisfare i rigorosi standard farmaceutici australiani assicurando che tutte le sue filiali seguano i processi di certificazione delle Buone Pratiche Agricole e di Raccolta (GACP).
L'espansione in Australia è in linea con il crescente fabbisogno dei pazienti, i cambiamenti normativi favorevoli e l'accesso sempre più ampio ai trattamenti con cannabis medicinale.
MedCana (OTC: SFWJ), una empresa holding especializada en tecnología agrícola y en la industria del cannabis, está explorando oportunidades para ingresar al mercado australiano de cannabis farmacéutica. Se proyecta que el mercado legal de cannabis en Australia alcanzará 540,6 millones de USD para 2030, con una tasa compuesta de crecimiento anual (CAGR) del 27,8% desde 2024 hasta 2030.
MedCana tiene como objetivo establecer una presencia como exportador y productor licenciado en Australia. El CEO de la empresa, Gabriel Díaz, destacó la creciente demanda de cannabis farmacéutico de alta calidad como una oportunidad perfecta para una rápida expansión. MedCana se compromete a cumplir con los rigurosos estándares farmacéuticos de Australia, asegurando que todas sus subsidiarias sigan los procesos de certificación de las Buenas Prácticas Agrícolas y de Recolección (GACP).
La expansión hacia Australia se alinea con la creciente demanda de pacientes, cambios regulatorios favorables y un acceso en expansión a tratamientos de cannabis medicinal.
MedCana (OTC: SFWJ)는 농업 기술과 대마 산업을 전문으로 하는 지주 회사로서 호주 제약 대마 시장에 진입할 기회를 탐색하고 있습니다. 호주의 합법적인 대마 시장은 2030년까지 5억 4천 6백만 USD에 이를 것으로 예상되며, 2024년부터 2030년까지 연평균 성장률(CAGR)은 27.8%에 이를 것으로 보입니다.
MedCana는 호주에서 수출업체 및 허가된 생산자로서의 입지를 확립할 계획입니다. 회사의 CEO인 가브리엘 디아즈는 고품질 제약 대마에 대한 증가하는 수요가 빠른 확장을 위한 완벽한 기회라고 강조했습니다. MedCana는 모든 자회사가 좋은 농업 및 수확 관행(GACP) 인증 절차를 따르도록 하여 호주의 엄격한 제약 기준을 충족하는 데 전념하고 있습니다.
호주로의 확장은 환자의 수요 증가, 유리한 규제 변화 및 의약용 대마 치료에 대한 접근 확대와 일치합니다.
MedCana (OTC: SFWJ), une société holding spécialisée dans la technologie agricole et l'industrie du cannabis, explore des opportunités pour entrer sur le marché australien du cannabis pharmaceutique. Le marché légal du cannabis en Australie devrait atteindre 540,6 millions USD d'ici 2030, avec un taux de croissance annuel composé (CAGR) de 27,8 % entre 2024 et 2030.
MedCana vise à établir une présence en tant qu'exportateur et producteur agréé en Australie. Le PDG de l'entreprise, Gabriel Diaz, a souligné la demande croissante de cannabis pharmaceutique de haute qualité comme une opportunité parfaite pour une expansion rapide. MedCana s'engage à respecter les normes pharmaceutiques rigoureuses de l'Australie en veillant à ce que toutes ses filiales suivent les processus de certification des Bonnes Pratiques Agricoles et de Collecte (GACP).
L'expansion vers l'Australie s'aligne avec la demande croissante des patients, des changements réglementaires favorables et un accès élargi aux traitements à base de cannabis médicinal.
MedCana (OTC: SFWJ), ein Holdingunternehmen, das sich auf Agrartechnologie und die Cannabisindustrie spezialisiert hat, untersucht Möglichkeiten für den Eintritt in den australischen Pharmakanabismarkt. Es wird prognostiziert, dass der legale Cannabismarkt in Australien bis 2030 540,6 Millionen USD erreichen wird, mit einer jährlichen Wachstumsrate (CAGR) von 27,8 % von 2024 bis 2030.
MedCana strebt an, sowohl als Exporteur als auch als lizenziert produzierendes Unternehmen in Australien präsent zu sein. Der CEO des Unternehmens, Gabriel Diaz, hob die wachsende Nachfrage nach hochwertigem Pharmacannabis als perfekte Gelegenheit für eine schnelle Expansion hervor. MedCana verpflichtet sich, die strengen pharmazeutischen Standards Australiens einzuhalten, indem gewährleistet wird, dass alle Tochtergesellschaften die Zertifizierungsprozesse der Guten Agrar- und Erntepraktiken (GACP) befolgen.
Die Expansion nach Australien stimmt mit der steigenden Patientennachfrage, günstigen regulatorischen Änderungen und dem wachsenden Zugang zu medizinischen Cannabissch treatments überein.
- None.
- None.
In the news release, MedCana Seeks Expansion into the Australian Pharmaceutical Cannabis Market Amid Projected Industry Growth, issued Oct. 3, 2024 by MedCana over PR Newswire, we are advised by the company that MedCana's stock ticker has been added to the release (OTC: SFWJ). The complete, corrected release follows:
MedCana Seeks Expansion into the Australian Pharmaceutical Cannabis Market Amid Projected Industry Growth
According to the latest reports,
MedCana's CEO, Gabriel Diaz, commented on the company's potential entry into
MedCana is committed to ensuring that all its subsidiaries follow stringent certification processes to meet global Good Agricultural and Collection Practices (GACP). With this approach, the company is positioned to meet
About SFWJ/MedCana
Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and the cannabis industries. As MedCana moves forward with its expansion plans, the Company remains committed to delivering on its promise of building a solid foundation for future growth of its holdings.
For more information, please visit: www.MedCana.net
Or connect with us via:
MedCana | LinkedIn
Facebook/MedCanaBio
MedCana (@MedCanaCo)/ X (Twitter)
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
View original content:https://www.prnewswire.com/news-releases/medcana-seeks-expansion-into-the-australian-pharmaceutical-cannabis-market-amid-projected-industry-growth-302266332.html
SOURCE MedCana
FAQ
What is MedCana's stock ticker symbol?
What is the projected size of the Australian legal cannabis market by 2030?
What is the CAGR for the Australian legal cannabis market from 2024 to 2030?
What role does MedCana (SFWJ) aim to play in the Australian cannabis market?
What certification process does MedCana (SFWJ) follow for its subsidiaries?
